• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.镰状细胞病家系队列中胎儿血红蛋白、白细胞计数和其他临床特征的遗传力。
Am J Hematol. 2019 May;94(5):522-527. doi: 10.1002/ajh.25421. Epub 2019 Feb 6.
2
Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.坦桑尼亚镰状细胞病中,胎儿血红蛋白修饰位点的基因变异可缓解贫血和白细胞增多症。
Am J Hematol. 2015 Jan;90(1):E1-4. doi: 10.1002/ajh.23859. Epub 2014 Oct 20.
3
The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.促炎细胞因子 GM-CSF 通过减弱镰状细胞病中 cAMP 依赖途径下调胎儿血红蛋白表达。
Blood Cells Mol Dis. 2011 Dec 15;47(4):235-42. doi: 10.1016/j.bcmd.2011.08.005. Epub 2011 Sep 25.
4
Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania.鉴定与坦桑尼亚镰状细胞病中胎儿血红蛋白极端水平相关的遗传变异和途径。
BMC Med Genet. 2020 Jun 5;21(1):125. doi: 10.1186/s12881-020-01059-1.
5
Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.原创研究:一项病例对照全基因组关联研究确定了镰状细胞病中胎儿血红蛋白的遗传修饰因子。
Exp Biol Med (Maywood). 2016 Apr;241(7):706-18. doi: 10.1177/1535370216642047. Epub 2016 Mar 27.
6
Variation and impact of polygenic hematologic traits in monogenic sickle cell disease.单基因镰状细胞病中多基因血液特征的变化及其影响。
Haematologica. 2023 Mar 1;108(3):870-881. doi: 10.3324/haematol.2022.281180.
7
Discovering the genetics underlying foetal haemoglobin production in adults.发现成人胎儿血红蛋白产生的潜在遗传学机制。
Br J Haematol. 2009 May;145(4):455-67. doi: 10.1111/j.1365-2141.2009.07650.x. Epub 2008 Mar 2.
8
Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.使用遗传风险预测模型集合预测镰状细胞贫血中的胎儿血红蛋白
Circ Cardiovasc Genet. 2014 Apr;7(2):110-5. doi: 10.1161/CIRCGENETICS.113.000387. Epub 2014 Mar 1.
9
Fetal hemoglobin in sickle cell anemia.镰状细胞贫血中的胎儿血红蛋白。
Blood. 2011 Jul 7;118(1):19-27. doi: 10.1182/blood-2011-03-325258. Epub 2011 Apr 13.
10
Implication of HMOX1 and CCR5 genotypes on clinical phenotype of Egyptian patients with sickle cell anemia.HMOX1 和 CCR5 基因型对埃及镰状细胞贫血患者临床表型的影响。
Ann Hematol. 2019 Aug;98(8):1805-1812. doi: 10.1007/s00277-019-03697-9. Epub 2019 Apr 27.

引用本文的文献

1
FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestries.非洲血统镰状细胞病中的FLT1及其他胎儿血红蛋白修饰候选基因座。
Nat Commun. 2025 Mar 1;16(1):2092. doi: 10.1038/s41467-025-57413-5.
2
Genetic regulation of fetal hemoglobin across global populations.全球人群中胎儿血红蛋白的遗传调控。
medRxiv. 2023 Mar 28:2023.03.24.23287659. doi: 10.1101/2023.03.24.23287659.
3
Sickle cell disease in the era of precision medicine: looking to the future.精准医学时代的镰状细胞病:展望未来。
Expert Rev Precis Med Drug Dev. 2019;4(6):357-367. doi: 10.1080/23808993.2019.1688658. Epub 2019 Nov 7.
4
Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements.利用新型小β珠蛋白基因调控区元件提高慢病毒载体的滴度和基因转移效率。
Mol Ther. 2020 Jan 8;28(1):328-340. doi: 10.1016/j.ymthe.2019.09.020. Epub 2019 Sep 28.
5
The genetics of human hematopoiesis and its disruption in disease.人类造血的遗传学及其在疾病中的异常。
EMBO Mol Med. 2019 Aug;11(8):e10316. doi: 10.15252/emmm.201910316. Epub 2019 Jul 17.

本文引用的文献

1
Disease Heritability Inferred from Familial Relationships Reported in Medical Records.从医疗记录中报告的家族关系推断出的疾病遗传率。
Cell. 2018 Jun 14;173(7):1692-1704.e11. doi: 10.1016/j.cell.2018.04.032. Epub 2018 May 17.
2
Sickle Cell Disease.镰状细胞病
N Engl J Med. 2017 Apr 20;376(16):1561-1573. doi: 10.1056/NEJMra1510865.
3
Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children.镰状细胞性视网膜病变的保护与儿童 HbF 水平升高和羟基脲的使用有关。
Br J Haematol. 2013 May;161(3):402-5. doi: 10.1111/bjh.12238. Epub 2013 Feb 6.
4
Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood.使用单核苷酸多态性衍生的基因组关系和限制最大似然估计复杂疾病之间的多效性。
Bioinformatics. 2012 Oct 1;28(19):2540-2. doi: 10.1093/bioinformatics/bts474. Epub 2012 Jul 26.
5
Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease.镰状细胞病患儿急性胸部综合征和疼痛性血管阻塞危象的血液流变学危险因素。
Haematologica. 2012 Nov;97(11):1641-7. doi: 10.3324/haematol.2012.066670. Epub 2012 Jun 11.
6
Genetic modifiers of sickle cell disease.镰状细胞病的遗传修饰物。
Am J Hematol. 2012 Aug;87(8):795-803. doi: 10.1002/ajh.23232. Epub 2012 May 28.
7
Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.血红蛋白 S 和缺失型遗传性胎儿血红蛋白持续存在的复合杂合子的胎儿血红蛋白水平和血液学特征。
Br J Haematol. 2012 Jan;156(2):259-64. doi: 10.1111/j.1365-2141.2011.08916.x. Epub 2011 Oct 24.
8
Fetal hemoglobin in sickle cell anemia.镰状细胞贫血中的胎儿血红蛋白。
Blood. 2011 Jul 7;118(1):19-27. doi: 10.1182/blood-2011-03-325258. Epub 2011 Apr 13.
9
Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.在三个已知影响胎儿血红蛋白水平的基因座上进行精细定位,解释了额外的遗传变异。
Nat Genet. 2010 Dec;42(12):1049-51. doi: 10.1038/ng.707. Epub 2010 Nov 7.
10
Common SNPs explain a large proportion of the heritability for human height.常见的单核苷酸多态性解释了人类身高遗传的很大一部分。
Nat Genet. 2010 Jul;42(7):565-9. doi: 10.1038/ng.608. Epub 2010 Jun 20.

镰状细胞病家系队列中胎儿血红蛋白、白细胞计数和其他临床特征的遗传力。

Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.

机构信息

Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Broad Institute of MIT and Harvard, Cambridge, Massachusetts.

出版信息

Am J Hematol. 2019 May;94(5):522-527. doi: 10.1002/ajh.25421. Epub 2019 Feb 6.

DOI:10.1002/ajh.25421
PMID:30680775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6449202/
Abstract

Sickle cell disease (SCD) is the most common monogenic disorder in the world. Notably, there is extensive clinical heterogeneity in SCD that cannot be fully accounted for by known factors, and in particular, the extent to which the phenotypic diversity of SCD can be explained by genetic variation has not been reliably quantified. Here, in a family-based cohort of 449 patients with SCD and 755 relatives, we first show that 5 known modifiers affect 11 adverse outcomes in SCD to varying degrees. We then utilize a restricted maximum likelihood procedure to estimate the heritability of 20 hematologic traits, including fetal hemoglobin (HbF) and white blood cell count (WBC), in the clinically relevant context of inheritance from healthy carriers to SCD patients. We report novel estimations of heritability for HbF at 31.6% (±5.4%) and WBC at 41.2% (±6.8%) in our cohort. Finally, we demonstrate shared genetic bases between HbF, WBC, and other hematologic traits, but surprisingly little overlap between HbF and WBC themselves. In total, our analyses show that HbF and WBC have significant heritable components among individuals with SCD and their relatives, demonstrating the value of using family-based studies to better understand modifiers of SCD.

摘要

镰状细胞病(SCD)是世界上最常见的单基因疾病。值得注意的是,SCD 存在广泛的临床异质性,无法用已知因素完全解释,特别是 SCD 的表型多样性在多大程度上可以用遗传变异来解释,这一点尚未得到可靠地量化。在这里,在一个由 449 名 SCD 患者和 755 名亲属组成的基于家庭的队列中,我们首先表明,5 个已知的修饰因子不同程度地影响 SCD 的 11 种不良结局。然后,我们利用受限最大似然程序来估计 20 种血液学特征的遗传力,包括胎儿血红蛋白(HbF)和白细胞计数(WBC),在从健康携带者到 SCD 患者的临床相关遗传背景下。我们报告了在我们的队列中 HbF 为 31.6%(±5.4%)和 WBC 为 41.2%(±6.8%)的新遗传力估计值。最后,我们证明了 HbF、WBC 和其他血液学特征之间存在共同的遗传基础,但令人惊讶的是,HbF 和 WBC 本身之间几乎没有重叠。总的来说,我们的分析表明,HbF 和 WBC 在 SCD 患者及其亲属中具有显著的遗传成分,这表明使用基于家庭的研究来更好地理解 SCD 的修饰因子具有价值。